Paik, P. K., Smit, E. F., Senellart, H., Veillon, R., Alt, J., Demedts, I., Nechushtan, H., Shi, J., Stroh, C., Juraeva, D., Solbes, M., Bruns, R., Johne, A., Kato, T. (2026). Profiling patients with
                    <i>MET</i>
                    exon 14 (
                    <i>MET</i>
                    ex14) skipping NSCLC with a sustained clinical benefit to tepotinib in VISION.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8612